Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,325.00    13.00 (0.56%)
Bid:
2,311.00
Ask:
2,313.00
Spread: 2.00 (0.087%)
Market Cap: £28.04b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Scrip Alternative

30 Aug 2022 15:43

RNS Number : 6400X
SSE PLC
30 August 2022
 

SSE PLC

 

FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2022

SCRIP ALTERNATIVE

SSE plc was notified on 29 August 2022 that a total of 26,101 shareholders have elected to receive the final dividend for the year ended 31 March 2022 of 60.2 pence per ordinary share in respect of 535,745,800 ordinary shares in the form of Scrip dividend. This will result in a reduction in final dividend cash funding of £322,518,972.

A total of 18,241,941 new ordinary shares, fully paid, will be issued on 22 September 2022, representing an increase of 1.71% on the issued share capital (excluding treasury shares) on the dividend record date of 29 July 2022. The relevant Scrip Reference Share Price was 1,768 pence per ordinary share.

In November 2021, as part of its fully funded Net Zero Acceleration Programme, SSE announced that the existing scrip dividend option for investors would be capped at 25% of investor uptake, through a share buy-back. Following notification of the final dividend elections SSE can confirm that overall scrip dividend take-up for the financial year ended 31 March 2022 was 38.33%. SSE therefore intends to initiate a share buy-back, in the period following the final dividend payment for the year ended 31 March 2022, in accordance with the authority granted by shareholders at SSE's Annual General Meeting on 21 July 2022 and Chapter 12 of the Listing Rules. The number of ordinary shares to be purchased will not exceed 6,904,083 ordinary shares, and the maximum pecuniary amount allocated to the Scrip buy-back is £125,000,000. SSE intends to complete this process by 31 March 2023.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVFLFSSTLIIVIF
Date   Source Headline
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company
2nd Dec 20252:41 pmRNSHolding(s) in Company
1st Dec 20258:55 amRNSHolding(s) in Company
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 202512:42 pmRNSHolding(s) in Company
28th Nov 202512:36 pmRNSHolding(s) in Company
28th Nov 202512:32 pmRNSDirector/PDMR Shareholding
27th Nov 20259:57 amRNSHolding(s) in Company
17th Nov 202511:30 amRNSDirector/PDMR Shareholding
14th Nov 20253:45 pmRNSDirector/PDMR Shareholding
13th Nov 20255:30 pmRNSSSE
12th Nov 20256:19 pmRNSResult of Equity Issue
12th Nov 20257:01 amRNSRetail Offer by RetailBook
12th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
12th Nov 20257:00 amRNSStrategic Update
7th Nov 202512:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
24th Oct 20252:30 pmRNSHolding(s) in Company
9th Oct 202511:42 amRNSDirector/PDMR Shareholding
7th Oct 20254:08 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSNOTIFICATION OF CLOSED PERIOD
1st Oct 20257:01 amEQSTotal Voting Rights
25th Sep 202511:00 amRNSDirector/PDMR Shareholding
22nd Sep 202511:46 amRNSDirector/PDMR Shareholding
16th Sep 202512:00 pmRNSAdditional Listing
9th Sep 20254:21 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amEQSTVR-Total Voting Rights
29th Aug 20257:00 amRNSBlock Listing 6-Monthly Return
28th Aug 20254:56 pmRNSScrip Alternative
26th Aug 20255:33 pmRNSSSEN TRANSMISSION ISSUES NEW €750m GREEN BOND
8th Aug 202511:12 amRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202510:39 amRNSSCRIP Dividend
31st Jul 202510:38 amRNSHolding(s) in Company
29th Jul 20253:51 pmRNSHolding(s) in Company
25th Jul 202511:05 amRNSHolding(s) in Company
23rd Jul 202512:13 pmRNSHolding(s) in Company
21st Jul 20253:44 pmRNSDirector/PDMR Shareholding
21st Jul 202511:49 amRNSHolding(s) in Company
17th Jul 20253:49 pmRNSResult of AGM
17th Jul 20257:00 amRNSQ1 Trading Statement
11th Jul 202511:00 amRNSDirector/PDMR Shareholding
9th Jul 20254:38 pmRNSDirector/PDMR Shareholding
8th Jul 20255:06 pmRNSDirector/PDMR Shareholding
1st Jul 20259:58 amRNSTotal Voting Rights
1st Jul 20257:09 amRNSSSENT response to RIIO-T3 Draft Determination
13th Jun 20251:15 pmRNSPublication of Annual Report and Accounts 2025
12th Jun 20255:04 pmRNSISSUE OF HYBRID CAPITAL SECURITIES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.